Indian Medical Association Assam welcomes doctors to a recorded live clinical experience sharing webinar session on "Early action in COVID-19-The benefits".
IMA Assam highlights
Module 1: Case presentation of COVID-19 patients - Dr. Brajendra Lahkar
●Case was presented and discussed with respect to:
○Symptoms
○Vital status
○Investigation
○Radiology report
○Treatment given in ICU
●Classification of COVID-19 with respect to presenting symptoms explained
●Study on COVID-19
●Risk factors resulting in poor diagnosis (comorbidity and laboratory parameters)
●Complications in COVID-19
●Treatment given in case explained
●Trails regarding use of dexamethasone, Remdesivir and convalescent plasma or immunoglobulin were described
●Conclusion regarding treatment was explained with personal experience
Module 2: Use of Favipiravir & early treatment options- Dr. Kripesh Ranjan Sarmah
●Introduction of present status of the disease and its management
Early treatment options:
●Medications used in early treatment was explained
●Use of Doxycycline and Ivermectin as combination in early treatment was described with help of a study
●Benefit of early use of Favipiravir explained with help of study and trails
●Conclusion -Use of Faviparivir in early treatment showed significant improvement
●Trail regarding use of Remdesivir was described
●Nocturnal oxygen therapy as early treatment option in treatment
●Umbilical cord blood as newer option explained
●Risk factors predicting prognosis
●Use of interleukin in COVID-19 management
Guidelines for mild cases of COVID-19:
●Government of India
●Government of Assam
Take home message:
● Early detection and prevention
● Even mild should be treated by moderate
● More research is required for further treatment
● Use medication as per severity and clinically indicated Module 3: Question and Answer session
We thank the Indian Medical Association Assam , for hosting this session and our sponsors Mylan Pharmaceuticals Pvt. Ltd. to make this program possible. Wish you a great learning experience.
